WallStreetZenWallStreetZen

NASDAQ: ABCL
Abcellera Biologics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Abcellera Biologics revenue was $75.13M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $44.9M, up 400.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ABCL annual revenue was $75.1M, with 160.6% growth year-over-year.

ABCL past revenue growth

How has ABCL's revenue growth performed historically?

Company
160.56%
Industry
465.24%
Market
90.32%
ABCL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ABCL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ABCL's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ABCL revenue history

Current Revenue
$75.1M
Current Earnings
-$146.4M
Current Profit Margin
-194.9%

Be the first to know when ABCL announces revenue.

ABCL Revenue History By Year

ABCL Yearly RevenueABCL RevenueABCL ChangeABCL Revenue Growth
2025-12-31$75.13M$46.30M+160.56%
2024-12-31$28.83M-$9.19M-24.17%
2023-12-31$38.03M-$447.40M-92.17%
2022-12-31$485.42M$110.22M+29.38%
2021-12-31$375.20M$142.05M+60.92%
2020-12-31$233.16M$221.54M+1,907.88%
2019-12-31$11.61M$2.78M+31.49%
2018-12-31$8.83MN/AN/A

1 of 1

Abcellera Biologics Revenue FAQ

What was ABCL's revenue last quarter?

On Invalid Date, Abcellera Biologics (NASDAQ: ABCL) reported Q4 2025 revenue of $44.85 million up 788.18% year over year. In the same quarter last year, Abcellera Biologics's revenue was $5.05 million.

What was Abcellera Biologics's revenue in 2025?

Abcellera Biologics's annual revenue for the twelve months ending Dec 31, 2025 was $75.13 million, a 160.56% increase year over year.

How much does Abcellera Biologics make in a day?

Based on Abcellera Biologics annual revenue for the past five years, ABCL makes an average of $549,376.99 per day.

What was Abcellera Biologics's annual revenue growth in the past year?

As of Q1 2026, Abcellera Biologics's revenue has grown 160.56% year over year. This is 304.68 percentage points lower than the US Biotechnology industry revenue growth rate of 465.24%. Abcellera Biologics's revenue in the past year totaled $75.13 million.

How much does Abcellera Biologics make in a year?

Abcellera Biologics's revenue by year for the past five years is:
  • Abcellera Biologics's revenue for the twelve months ending Dec 31, 2025 was $75.13 million, a 160.56% increase year over year.
  • Abcellera Biologics's annual revenue for Dec 31, 2024 was $28.83 million, a 24.17% decrease from 2023.
  • Abcellera Biologics's annual revenue for 2023 was $38.03 million, a 92.17% decrease from 2022.
  • Abcellera Biologics's annual revenue for 2022 was $485.42 million, a 29.38% increase from 2021.
  • Abcellera Biologics's annual revenue for 2021 was $375.20 million, a 60.92% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.